Cardiac amyloidosis remains significantly underdiagnosed in patients undergoing TAVR: analysis of National Inpatient Sample

Amyloid. 2023 Jun;30(2):246-247. doi: 10.1080/13506129.2022.2159369. Epub 2022 Dec 21.

Authors

Dimitrios Terentes-Printzios¹, Alexios S Antonopoulos¹, Mohamed Omer², Ioannis Panagiotopoulos¹, Konstantinos Toutouzas¹, Konstantinos Tsioufis¹, Islam Elgendy³, Charalambos Vlachopoulos¹

Affiliations

¹ 1st Cardiology Department, Hippokration Hospital, National and Kapodistrian University of Athens, Athens, Greece.
² Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.
³ Gill Heart Institute, University of Kentucky, Lexington, KY, USA.

PMID: 36541785
DOI: 10.1080/13506129.2022.2159369

No abstract available

MeSH terms

Amyloidosis*
Aortic Valve Stenosis* / surgery
Humans
Inpatients
Risk Factors
Transcatheter Aortic Valve Replacement*
Treatment Outcome